https://charts.traderzeitung.de/phases/US46333X1081
string(1404) "{"isin":"US46333X1081","name":"Ironwood Pharmaceuticals Inc","stock_id_xnas":7874185,"stock_id_xnys":null,"generated_at":"2026-07-18 06:50:00","days":[{"date":"2026-07-15","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.995,"close_at":"2026-07-15 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-16","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.88,"close_at":"2026-07-16 21:59:00","complete":true,"perf_pct":-2.8786},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-17","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.85,"close_at":"2026-07-17 21:59:00","complete":true,"perf_pct":-0.7732},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Ironwood Pharmaceuticals Aktie News & Nachrichten

Ironwood Pharmaceuticals Aktie News & Nachrichten

[WKN: A0X789 | Symbol: IRWD]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Ironwood Pharmaceuticals Chart

Artikel aus der Redaktion der Trader-Zeitung

Ironwood Pharmaceuticals: Starker Umsatzausblick 2026 lenkt den Fokus zurück auf Linzess!

Zum Jahresbeginn verbucht die Aktie von Ironwood Pharmaceuticals  einen deutlichen Kursanstieg. Der...

  • 1
MT Newswires 27.05.2026 17:11 Uhr

Ironwood sagt, US-FDA genehmigt Verwendung von Linzess bei Kindern ab zwei Jahren mit funktioneller Verstopfung

11:11 AM EDT, 05/27/2026 (MT Newswires) -- Ironwood Pharmaceuticals (IRWD) hat sich die Zulassung der US Food and Drug Administration für die erweiter